As the letter states, the development of clinical algorithms, involves significant use of judgment by their creators and creates the opportunity for creative bias, from conflicts of interest, limited perspectives on the lives of racial minorities, or implicit racial bias to be introduced into the algorithm.
Markey highlights the risks of bias in clinical algorithms.
Share
More from Ed Markey
I will fight to extend these same protections to TPS holders from Syria, Venezuela, El Salvador, Ukraine, Sudan, and every other community that has been forced to seek safety in the United States.
The FDA is correct in its recognition that the GRAS rule is flawed and overdue for correction, but this proposed rule will not protect families from exposure to dangerous food chemicals.
This dangerous deal is the starting gun for a Middle East nuclear arms race.
The end of Haiti TPS will separate families who wish for nothing more than safety and will hurt local communities across the nation.
Other voices in this conversation
